west china medical publishers
Keyword
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Keyword "取石" 38 results
  • 经皮经肝胆道镜碎石取石术治疗胆肠吻合术后肝胆管结石病

    目的探讨经皮经肝胆道镜碎石取石术(PTCSL)必要时联合球囊扩张治疗胆肠吻合术后肝胆管结石病的可行性及安全性。方法重庆医科大学附属第二医院 2015 年 12 月至 2020 年 12 月期间共有 54 例胆肠吻合术后肝胆管结石病患者接受 PTCSL 必要时联合球囊扩张治疗(符合纳入标准)。回顾性收集患者的一般资料、手术情况、术后情况以及术后随访资料。结果54 例患者中有 52 例(96.3%)行 PTCSL 治疗成功,2 例因为胆肠吻合口完全闭塞而失败。术中出血量的中位数为 55 mL(15~520 mL);取净结石 48 例(88.9%),结石残留 6 例(11.1%)。术后并发症发生率为 27.8%(15/54),无围手术期死亡患者。取净结石的 48 例患者获随访,中位随访时间 33 个月(2~60 个月),有 10 例结石复发,复发率为 20.8%(10/48)。结论PTCSL 必要时联合球囊扩张治疗胆肠吻合术后肝胆管结石病具有良好的安全性和可行性,但是术后需要注意预防结石复发。

    Release date:2021-11-30 02:39 Export PDF Favorites Scan
  • he Application of Retroperitoneoscopic Ureterolithotomy in Treatment of Impacted Stone of Upper Ureter (Reports of 58 Cases)

    摘要:目的:探讨后腹腔镜输尿管切开取石术治疗嵌顿性输尿管结石的临床价值和技术要点。 方法:2006年12月至 2009年3月,对58例嵌顿性输尿管中上段结石采用后腹腔镜输尿管切开取石术,术中取石后于镜下直接置入双J管,间段缝合输尿管切口。 结果:58例手术均获成功,无中转开放手术,结石清除率100%。术后创腔引流液量少,3~5d拔除引流管,1周出院,术后3周膀胱镜下拔除双J管。随访1~27个月,B超复查显示肾积水明显好转或消失,无结石复发。 结论:后腹腔镜输尿管切开取石术治疗嵌顿性输尿管结石具有创伤小\疗效好、术后恢复快等特点,明显优于开放手术及其它手术,值得推广应用。Abstract: Objective: To summarize our experience and evaluate the outcome of retroperitoneal laparoscopic ureterolithotomy of the upper ureter impacted stone. Methods: Between December 2006 and March 2009, 58 patients underwent retroperitoneal laparoscopic ureterolithotomy of the upper ureter. After removal of the stones, the double J was put in and interrupted suture was performed for upper ureter. Results: Retroperitoneoscopic ureterolithotomy was successful in all patients, there was neither ureteral stricture nor recurrent calculus, the blood loss ranged from 510 mL, without urine leakage occurred.The mean hospital stay was 7 days, after 3 weeks double J was removed by cystoscopy. With 127 months followup, the hydronephrosis relieved and no recurrence of ureter calculus founded. Conclusion:Retroperitoneoscopic ureterolithotomy is a safe and effective minimally invasive operation, and worth to generalization.

    Release date:2016-09-08 10:12 Export PDF Favorites Scan
  • Value of percutaneous transhepatic choledochoscopic lithotripsy in treatment of recurrent type Ⅱa hepatolithiasis

    ObjectiveTo investigate the feasibility and safety of percutaneous transhepatic choledochoscopic lithotripsy (PTCSL) in the treatment of recurrent type Ⅱa hepatolithiasis.MethodsAll of 293 patients with recurrent type Ⅱa hepatolithiasis admitted to the Second Affiliated Hospital of Chongqing Medical University from December 2010 to December 2017 were collected retrospectively, 82 of whom were treated with the PTCSL (PTCSL group), 211 of whom were treated with traditional open surgery (open group). The patients were matched according to the ratio of 1∶1 by using the method of propensity score matching, then the patients were compared after matching.ResultsA total of 59 pairs were successfully matched, that was, there were 59 patients in the PTCSL group and open group, respectively. Compared with the open group, the PTCSL group had the similar conditions such as the gender, age, preoperative Child-Pugh classification, and times of previous biliary operations, etc. (P>0.050). There was no perioperative death in both groups. There were no significant differences between the two groups in the success rate, operation time, times of operations, time of T tube removal after operation, stone residual rate, and stone recurrence rate (P>0.050). Although the hospital costs of the PTCSL group was higher than that of the open group (P<0.050), the PTCSL group had various advantages, such as less intraoperative bleeding, smaller incisional scar, shorter hospital stay and postoperative ventilation time, and lower rate of total postoperative complications (P<0.050).ConclusionsAfter learning curve, PTCSL has many advantages over traditional open surgery in treatment of recurrent type Ⅱa hepatolithiasis. PTCSL is a minimally invasive surgery, which is safe and effective.

    Release date:2020-12-25 06:09 Export PDF Favorites Scan
  • Clinical Experience of Laparoscopic Common Bile Duct Exploration

    目的 探讨腹腔镜胆总管切开取石术的优势,总结手术操作经验及常见并发症的预防与处理。方法回顾性分析我院1999年6月至2010年4月期间收治的108 例胆管结石患者行腹腔镜胆总管探查取石术的手术方法、操作要点及并发症的处理。结果 腹腔镜手术成功 105例, 中转开腹3例; 手术时间(120±20) min,出血量(25±5) ml,住院时间(9±1) d; 术后发生胆道出血3例,漏胆7 例,残余结石6 例; 全组无死亡病例。结论 腹腔镜胆总管切开取石术具有创伤小、痛苦轻、恢复快、对腹腔脏器干扰小、住院时间短等优点,值得临床推广。

    Release date:2016-09-08 10:49 Export PDF Favorites Scan
  • Comparison of Clinical Effectiveness on Two Kinds of Minimally Invasive Treatment for Cholecystolithiasis with Choledocholithiasis

    Objective To evaluate the clinical effectiveness of laparoscopic cholecystectomy and laparoscopic common bile duct exploration (LC+LCBDE) and endoscopic retrograde cholangiopancreatography/endoscopic sphincterectomy with LC(ERCP/EST+LC) in treatment for cholecystolithiasis with choledocholithiasis. Methods From January 2008 to July 2011, 127 patients suffered from cholecystolithiasis with choledocholithiasis underwent either LC+LCBDE(85 cases, LC+LCBDE group) or ERCP/EST+LC(42 cases, ERCP/EST+LC group) were collected retrospectively. The clearance rate of calculus, hospital stay, hospitalization expenses, and the rate of postoperative complications were compared between two groups. Results Eighty-five patients were performed successfully in the LC+LCBDE group, out of which 54 patients had primary closure of common bile duct (LC+LCBDE primary closure group), whereas in 28 patients common bile ducts were closed over T tube (LC+LCBDE+T tube group). Forty-two patients were performed successfully in the ERCP/EST+LC group. There were no differences in the clearance rate of calculus〔100%(82/82) versus 97.37%(37/38), P=0.317〕 and postoperative complications rate 〔(4.71% (4/85) versus 4.76%(2/42), P=1.000〕 between the LC+LCBDE group and ERCP/EST+LC group. The median (quartile) hospital stay in the LC+LCBDE group was shorter than that in the ERCP/EST+LC group 〔12 (6) d versus 17(9) d, P<0.001〕. In the LC+LCBDE primary closure group, both median (quartile)?hospital stay and median(quartile) hospitalization expenses were less than those of ERCP/EST+LC〔hospital stay:11(5) d versus 17(9) d, P<0.001;hospitalization expenses:27 054(8 452) yuan versus 31 595(11 743) yuan, P=0.005〕 . Conclusions In the management of patients suffered from cholecystolithiasis with choledocholithiasis, both LC+LCBDE and ERCP/EST+LC are safe and effective. LC+LCBDE, especially primary closure after LCBDE, is associated with significantly less costs as compared with ERCP/EST+LC. Moreover, patients can be cured by LC+LCBDE through one-stage treatment with the protection of the papilla function and no limits to the amount or size of the choledocholithiasis. The LC+LCBDE is a preferable choice for the appropriate cases of cholecystolithiasis with choledocholithiasis.

    Release date:2016-09-08 10:36 Export PDF Favorites Scan
  • Clinical Experience of Laparoscopic Choledocholithotomy and Primary Suture: a Report of 58 Cases

    ObjectiveTo explore the clinical efficacy and surgical techniques of laparoscopic choledocholithotomy and primary suture. MethodsWe retrospectively analyzed the clinical data of 58 patients who underwent laparoscopic choledocholithotomy and primary suture between January 2009 and December 2014. ResultsAll the 58 patients underwent the surgery successfully. Operation time was 45-125 minutes, averaging 75 minutes. Intraoperative blood loss was between 10 and 50 mL with an average of 20 mL. Postoperative hospital stay was 5-14 days with an average of 7 days. Four cases of biliary leakage were cured by conservative treatment. ConclusionWith operation indications strictly grasped and skillful operation techniques, laparoscopic choledocholithotomy and primary suture are safe and reliable with a good curative effect.

    Release date:2016-10-02 04:54 Export PDF Favorites Scan
  • Clinical Analysis for Reason and Treatment Strategy of Gallbladder Muddy Stones after Cholecystolithotomy

    ObjectiveTo discuss the reason and treatment strategy of gallbladder muddy stones after cholecysto-lithotomy. MethodsThe clinical data of 62 patients with gallbladder muddy stones after cholecystolithotomy who were treated in our hospital from December 2008 to December 2014 was analyzed retrospectively. ResultsThere were 43 patients without any symptom and 19 patients with acute cholecystitis in 62 patients. Four patients were diagnosed with septation gallbladder, 6 patients with long and tortuous cystic duct, 3 patients with calculus of cystic duct, 4 patients with common bile duct stones, 39 patients with periampullary diverticula, 18 patients with pancreaticobiliary maljunction, 6 patients with duodenal papilla stenosis, 29 patients with duodenal papillitis, and 3 patients with duodenal papilla adenocarcinoma. Two patients were treated with laparoscopic cholecystectomy (LC), 1 patient with endoscopic sphincterotomy (EST) /endoscopic balloon dilation (EPBD) and LC, 1 patient with percutaneous transhepafic gallbladder drainage (PTGD) and open cholec-ystectomy, 14 patients with PTGD and EST/EPBD, 1 patient with PTGD and hepatocholangioplasty with the use of gallbladder (HG), 34 patients with EST/EPBD, 3 patients with EST/EPBD and endoscopic biliay metal stent drainage (EBMSD), 5 patients with HG, and 1 patient with EST/EPBD and HG. The gallbladder muddy stones disappeared after operations in 55 patients with gallbladder reserved, and gallbladder ejection fraction increased from (42±12) % to (59±16) %. Of the 62 patients, 53 patients were followed up for 6 months to 6 years (the median time was 3.6-year). During the follow-up period, 3 patients were diagnosed with gallbladder stones, 2 patients with common bile duct stones, and 2 patients with intrahepatic and extrahepatic bile duct stones. ConclusionBile efferent tract obstruction is the important reason for the formation of gallbladder stones. HG, EST, and balloon expansion are the efficient methods to resolve the bile efferent tract obstruction.

    Release date: Export PDF Favorites Scan
  • A Clinical Study on Tauro Ursodeoxycholic Acid for the Relapse of Cholelithiasis after Gallbladder-Protected Lithotomy

    Objective To evaluate the clinical application value of the tauro ursodeoxycholic acid (TUDCA) for preventing the relapse of lithiasis after the gallbladder-protected lithotomy. Methods Totally 80 cholecyslithiasis patients in Chengdu General Military Hospital who met the demand of lithotomy in protecting gallbladder were divided into two groups by random permutations, with 40 patients in each. The calculus was removed by using the percutaneous ultrasonic lithotripsy in order to preserve the well-functioning gallbladder. The patients in the trial group were given TUDCA after surgery for two years, whereas the patients in the control group received the same nursing and diet therapies without medication. The thickness of gallbladder wall and the contraction function of gallbladder were checked two years after surgery, the statistics of the recurrence rate of liary calculus symptoms and cholecyslithiasis were conducted, and the comparison between those two groups was performed. Results All the operations of gallbladder-protected lithotomy were successful. There was significant difference between those two groups two years after surgery in terms of the thickness of gallbladder wall and the contraction function of gallbladder (Plt;0.05). The relapse of lithiasis was remarkably decreased in the trial group (Plt;0.05). Conclusion The application of TUDCA for patients with gallbladder-protected lithotomy can prevent the relapse of cholecyslithiasis.

    Release date:2016-09-07 11:06 Export PDF Favorites Scan
  • Minimally Invasive Percutaneous Nephrolithotomy Report of 41 Cases

    目的:探讨微创经皮肾穿刺取石术(MPCNL)治疗肾结石的疗效。方法:采用MPCNL治疗41例肾结石患者,其中肾石30例(结石直径gt;2.0 cm),输尿管上段结石11例(结石直径1.0~2.0 cm);单侧结石37例,双侧结石4例。结果:41例手术均获成功。手术时间45~120 min,平均52.7 min,无一例改开放手术。本组肾结石病例单次结石清除26例(86.7%),4例残余结石行二期手术取净;输尿管上段单次结石清除率100%。结论:MPCNL 是一种有效的治疗肾结石的方法,并具有创伤小、取石率高、恢复快等优点。

    Release date:2016-09-08 09:54 Export PDF Favorites Scan
  • Therapeutic and safety evaluation of third-generation super-mini percutaneous nephrolithotomy in treating ≤ 2.5 cm kidney calculi with high CT value

    ObjectiveTo evaluate the efficacy and safety of the third-generation super-mini percutaneous nephrolithotomy (SMP) for the treatment of kidney calculi with diameter of ≤2.5 cm and CT value of ≥700 Hu, and discuss the feasibility of adopting the technology in primary hospitals.MethodsThe clinical data of 64 patients with unilateral kidney calculi (CT value ≥700 Hu, diameter ≤2.5 cm) treated in the People’s Hospital of Leshan Central District between July 2017 and July 2018 were retrospectively analyzed. After random assignment, 30 patients were treated with SMP and 34 were with mini percutaneous nephrolithotomy (MPCNL). The pre-, intra-, and post-operative data were compared and analyzed to evaluate the efficacy and safety.ResultsThe unilateral lesion operations of both groups were successfully completed in the first phase. All patients were given double J tubes after operation, and there were no major complications such as post-operative hemorrhage and sepsis. There was no statistically significant difference in the post-operative hemoglobin decrease, post-operative immediate stone removal rate, post-operative stone removal rate after one month, or the rate of procalcitonin >0.1 μg/L between the two groups (P>0.05). The differences in the lithotripsy time [(29.63±6.28) vs. (25.21±5.19) minutes], post-operative hospital stay [(5.33±0.61) vs. (9.44±0.96) days], rate of indwelling renal fistula (3.3% vs. 50.0%), analgesic demand rate (10.0% vs. 58.8%), and postoperative infectious fever rate (6.7% vs. 26.5%) between SMP group and MPCNL group were statistically significant (P<0.05).ConclusionsSMP has the advantages of less trauma, low systemic inflammatory response syndrome incidence, less pain, quick rehabilitation, short hospital stay, tubeless after surgery, etc. It is worthy of extensive promotion in primary hospitals.

    Release date:2019-08-15 01:18 Export PDF Favorites Scan
4 pages Previous 1 2 3 4 Next

Format

Content